Sulfamethoxazole/Trimethoprim | Interleukin Related interleukin-related.com

Product Name :
Sulfamethoxazole/Trimethoprim

Search keywords :
Trimethoprim

drugId :
null

Target Vo:
Dihydropteroate synthase

Target Vo Short Name :
DHPS

Moa_Name:
Dihydropteroate synthase inhibitors

First Approval Country :
United States

First Approval Date Filter:
1973

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Bangabandhu Sheikh Mujib Medical University

Active Indication_Name:
Bacterial Infections

In Active Indication_Name:
Vesico-Ureteral Reflux

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Bavituximab web
Lutikizumab Biological Activity
PRDX3 Antibody (YA909): PRDX3 Antibody (YA909) is an unconjugated, approximately 28 kDa, human-derived, anti-PRDX3 (YA909) monoclonal antibody. PRDX3 Antibody (YA909) can be used for: WB, IF-Cell, IHC-P, FC, IP expriments in human background without labeling.

Author: Interleukin Related

Related Posts